Vedanta Biosciences Inc - Boston, Massachusetts 02116

Vedanta Biosciences Inc is categorized under Research and Development Laboratories in Boston, MA .

Business Name: Vedanta Biosciences Inc
Contact Person: Daphne Zohar
Address: 500 Boylston St # 1600, Boston, Massachusetts 02116
Phone Number: (617) 482-2333
Website Address: puretechventures.com
Annual Revenue (USD): $50.000 to $99.999
Founding Year: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:
Related Businesses: Prism Technology Search LLC - Boston, MA 02116
Ensof Biosystems - Boston, MA 02116
Morgan Keegan Technology Group - Boston, MA 02116
Karuna Pharmaceuticals - Boston, MA 02116
Hercules Technology Growth - Boston, MA 02116
Ascensys Technology - Boston, MA 02116
Advant Technologies Group LLC - Boston, MA 02116
Innovations Technology Tools - Boston, MA 02116
Prism Science Works Inc - Boston, MA 02116
Advanced Aerosol Technology - Boston, MA 02116
Wintsec Technologies - Boston, MA 02116
Population Research For Environmental Sustainability (Pres) - Boston, MA 02116
Libra Biosciences - Boston, MA 02116

The company Vedanta Biosciences Inc provides B2B services in the form of Research and Development Laboratories from its single location in Massachusetts. 1 to 4 employees work for Vedanta Biosciences Inc, and the business now earns $50.000 to $99.999 per annum.

Vedanta Biosciences Inc was launched in 2011 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 . To contact Vedanta Biosciences Inc, please call Daphne Zohar with the phone number (617) 482-2333 or visit its single location at 500 Boylston St # 1600 in Boston, Massachusetts 02116.

The location of the single location can also be found using the coordinates 42.350637,-71.07479. Read more details about this business on the webpage puretechventures.com or follow the company’s social media accounts, on Twitter and on Facebook.